{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T17:14:40Z","timestamp":1773162880149,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annalsofvascularsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.avsg.2020.08.124","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T11:38:15Z","timestamp":1599133095000},"page":"298-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Outcomes after Endovascular Stent Placement for Long-Segment Superficial Femoral Artery Lesions"],"prefix":"10.1016","volume":"71","author":[{"given":"Nader","family":"Zamani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherene E.","family":"Sharath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocky C.","family":"Browder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal R.","family":"Barshes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan D.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Sr.","given":"Joseph L.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panos","family":"Kougias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houssam K.","family":"Younes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.avsg.2020.08.124_bib1","doi-asserted-by":"crossref","first-page":"II30","DOI":"10.1177\/15266028060130S207","article-title":"Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries","volume":"13","author":"Laird","year":"2006","journal-title":"J Endovasc Ther"},{"issue":"Suppl 1","key":"10.1016\/j.avsg.2020.08.124_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2006.09.024","article-title":"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"33","author":"Norgren","year":"2007","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2020.08.124_bib3","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/1526602815592206","article-title":"An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"22","author":"Jaff","year":"2015","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2020.08.124_bib4","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jvs.2013.01.050","article-title":"Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease","volume":"58","author":"Geraghty","year":"2013","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2020.08.124_bib5","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jacc.2013.05.079","volume":"62","author":"Lammer","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2020.08.124_bib6","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jvs.2017.05.110","article-title":"Evolution and current use of technology for superficial femoral and popliteal artery interventions for claudication","volume":"66","author":"Schneider","year":"2017","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2020.08.124_bib7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jvs.2016.03.420","article-title":"Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease","volume":"64","author":"Stoner","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2020.08.124_bib8","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.amjsurg.2009.07.017","article-title":"Subintimal placement of covered stent versus subintimal balloon angioplasty in the treatment of long-segment superficial femoral artery occlusion","volume":"198","author":"Kougias","year":"2009","journal-title":"Am J Surg"},{"key":"10.1016\/j.avsg.2020.08.124_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jvir.2012.10.004","volume":"24","author":"Saxon","year":"2013","journal-title":"J Vasc Interv Radiol"},{"issue":"2 Suppl 2","key":"10.1016\/j.avsg.2020.08.124_bib10","first-page":"II82","article-title":"Evolving modalities for femoropopliteal interventions","volume":"16","author":"Ansel","year":"2009","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2020.08.124_bib11","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jvs.2015.04.436","article-title":"Three-year outcome of the heparin-bonded Viabahn for superficial femoral artery occlusive disease","volume":"62","author":"Golchehr","year":"2015","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2020.08.124_bib12","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jvs.2007.12.050","article-title":"Contemporary outcomes after superficial femoral artery angioplasty and stenting: the influence of TASC classification and runoff score","volume":"47","author":"Ihnat","year":"2008","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2020.08.124_bib13","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/j.jacc.2013.03.034","article-title":"Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies","volume":"61","author":"Dake","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2020.08.124_bib14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/1526602817749242","article-title":"Novel nitinol stent for lesions up to 24 cm in the superficial femoral and proximal popliteal arteries: 24-month results from the TIGRIS randomized trial","volume":"25","author":"Laird","year":"2018","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2020.08.124_bib15","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2019.02.016","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"69","author":"Conte","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2020.08.124_bib16","first-page":"555","article-title":"12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty","volume":"84","author":"Marmagkiolis","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2020.08.124_bib17","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jvs.2008.06.006","article-title":"Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease","volume":"48","author":"Dosluoglu","year":"2008","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2020.08.124_bib18","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ejvs.2015.07.018","article-title":"Treatment of TASC C and D femoropopliteal lesions with paclitaxel eluting stents: 12 month results of the STELLA-PTX registry","volume":"50","author":"Davaine","year":"2015","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2020.08.124_bib19","first-page":"115","article-title":"The Zilver(R) PTX(R) single arm study: 12-month results from the TASC C\/D lesion subgroup","volume":"54","author":"Bosiers","year":"2013","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.avsg.2020.08.124_bib20","first-page":"229","article-title":"Effectiveness of Zilver PTX eluting stent in TASC C\/D lesions and restenosis","volume":"55","author":"Leopardi","year":"2014","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.avsg.2020.08.124_bib21","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.115.016900","article-title":"Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial","volume":"133","author":"Dake","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2020.08.124_bib22","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.jvs.2013.05.094","article-title":"Clinical consequence of bare metal stent and stent graft failure in femoropopliteal occlusive disease","volume":"58","author":"Vartanian","year":"2013","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2020.08.124_bib23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00270-016-1513-0","article-title":"Peripheral stent thrombosis leading to acute limb ischemia and major amputation: incidence and risk factors in the aortoiliac and femoropopliteal arteries","volume":"40","author":"Katsanos","year":"2017","journal-title":"Cardiovasc Interv Radiol"},{"key":"10.1016\/j.avsg.2020.08.124_bib24","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jacc.2004.11.026","article-title":"Prevalence and clinical impact of stent fractures after femoropopliteal stenting","volume":"45","author":"Scheinert","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2020.08.124_bib25","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.jvir.2007.07.011","article-title":"Long-term patency and clinical outcome of the Viabahn stent-graft for femoropopliteal artery obstructions","volume":"18","author":"Saxon","year":"2007","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.avsg.2020.08.124_bib26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/1526602818771345","article-title":"Edge stenosis after covered stenting for long superficial femoral artery occlusive disease: risk factor analysis and prevention with drug-coated balloon angioplasty","volume":"25","author":"Lin","year":"2018","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2020.08.124_bib27","doi-asserted-by":"crossref","first-page":"e011245","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.avsg.2020.08.124_bib28","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/jamacardio.2019.0325","article-title":"Association of survival with femoropopliteal artery revascularization with drug-coated devices","volume":"4","author":"Secemsky","year":"2019","journal-title":"JAMA Cardiol"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509620308074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509620308074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:59:59Z","timestamp":1760187599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509620308074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":28,"alternative-id":["S0890509620308074"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2020.08.124","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes after Endovascular Stent Placement for Long-Segment Superficial Femoral Artery Lesions","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2020.08.124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}